Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for LEVODOPA
- Bioequivalence Study of Entacapone,Levodopa and Carbidopa Tablets in the Postprandial State in Healthy Chinese Subjects
- Effectiveness of Botulinum Toxin in Freezing of Gate in Parkinson's Disease Walking in Parkinson's Disease.
- A Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of UCB0022 in Study Participants With Advanced Parkinson's Disease
- Personalized Real-Time DBS and PD Mechanisms
- Effect of Folic Acid in Levodopa Treated Parkinson's Disease Patients
- A Study to Investigate The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7486967 in Participants With Early Idiopathic Parkinson's Disease
- Istradefylline Effect Protocol on Parkinson's Disease Tremor
- Lenrispodun as Adjunctive Therapy in the Treatment of Patients With Motor Fluctuations Due to Parkinson's Disease
- Pharmacological Agents for Chronic Spinal Cord Injury (SCI)
- The Treatment of Adrenal Crisis With Inhaled Prednisolone
- Effect of Doxycycline in Levodopa Treated Parkinson's Disease Patients
- Effect of Levodopa on Cardiovascular Autonomic Function in Parkinson's Disease
- Sustained Release Oral Formulation for Treatment of Parkinson's Disease
- Project 1 Aim 2, Adaptations of the Brain in Chronic Pain With Opioid Exposure
- A Pharmacodynamics and Safety Study of DSP-9632P in Patients With Levodopa-Induced Dyskinesia in Parkinson's Disease
- Istradefylline for Parkinson Disease With Cognitive Impairment
- A Study to Evaluate the Efficacy and Safety of Safinamide Mesilate as Add-on Therapy to Levodopa in Parkinson's Disease Participants With Motor Fluctuation in South Korea
- Efficacy, Safety and Pharmacokinetic Study of CPL500036 in Patients With Levodopa Induced Dyskinesia
- The Role of Brain Dopamine in Chronic Pain
- Bioavailability of Levodopa 250 mg and Carbidopa 25 mg With Regards to Reference Product
- Multiple N-of-1 Trials of (Intermittent) Hypoxia Therapy in Parkinson's Disease
- Study to Assess the Safety, Tolerability and Preliminary Efficacy of NLX-112 Versus Placebo in L-dopa-induced Dyskinesia
- Treating Early Stage Diabetic Retinopathy
- Comparative Bioavailability Study of Carbidopa/Levodopa Extended-Release Tablets Under Fasting and Fed Conditions
- Open-label Safety Study of Dipraglurant (ADX48621) in Patients With Parkinson's Disease Receiving Levodopa-based Therapy
- Study to Assess How ABBV-951 is Absorbed When Administered at Different Subcutaneous Sites of Adult Participants With Parkinson's Disease
- Novel Non-opioid Post-surgical Pain Treatment in Females
- NE3107 Activity and Safety in Patients With Parkinson's Disease Using Levodopa
- A Study of the Efficacy and Safety of Carbidopa-Levodopa Extended-Release Tablets in Patients With Parkinson's Disease
- eArly levoDopa With Opicapone in Parkinson's paTients wIth motOr fluctuatioNs.
- OpicApone Sleep dISorder
- OpiCapone Effect on Motor Fluctuations and pAiN
- Early ParkinSon wIth L-DOPA/DDCI and OpicapoNe (EPSILON Study)
- Dopaminergic Mechanism of Memory Impairment in Parkinson's Disease
- Clinical Study of Stalevo in the Treatment of Early Parkinson's Disease
- Randomized, Double-Blind, Active Placebo-Controlled Study of Ketamine to Treat Levodopa-Induced Dyskinesia
- Apomorphine Effects on Pain in Parkinson's Disease
- Role and Mechanism of Probiotics in Improving Motor Symptoms in Mild to Moderate Parkinson's Disease
- Study to Investigate the Effect of Hypoestes Rosea Powder in Parkinson's Disease
- Dipraglurant (ADX48621) for the Treatment of Patients With Parkinson's Disease Receiving Levodopa-based Therapy
- A Study to Evaluate the add-on Efficacy and Safety of Opicapone 50 mg or an Extra Dose of L-DOPA 100 mg for the Treatment of Wearing-off in Patients With PD
- Study To Assess Adverse Events and Change in Disease Activity Of 24-hour Continuous Subcutaneous Infusion Of ABBV-951 In Adult Participants With Advanced Parkinson's Disease
- Research on Translational Outcomes of Alcohol (Project RETRO)
- Levodopa and Exercise for Older Adults With Depression and Psychomotor Slowing
- Effect of Verdiperstat on Microglial Activation in Well-characterized MSA Patients
- PK Study of WD-1603 in Healthy Subjects
- Improving Quality of Life in Early Parkinson's Disease
- A Single Oral Dose, Crossover Comparative PK Study of WD-1603 in Healthy Subjects Under Fasting Conditions
- Flexible-Dose, Adjunctive Therapy Trial in Adults With Parkinson's Disease With Motor Fluctuations
- WD-1603 PK Study Under Fasting and Fed Conditions in Healthy Subjects
- 1/2-Dopaminergic Dysfunction in Late-Life Depression (The D3 Study)
- Dopaminergic Dysfunction in Late-Life Depression
- A Clinical Study of Mesdopetam in Patients With Parkinson's Disease Experiencing Levodopa Induced Dyskinesia
- Ambroxol as a Novel Disease Modifying Treatment for Lewy Body Dementia
- Effect of GOCOVRI (Amantadine, Extended Release Capsules) on Gait in Parkinson's Disease
- Study Comparing Continuous Subcutaneous Infusion Of ABBV-951 With Oral Carbidopa/Levodopa Tablets For Treatment Of Motor Fluctuations In Adult Participants With Advanced Parkinson's Disease
- Extension Study To Evaluate Safety And Tolerability Of 24-Hour Daily Exposure Of Continuous Subcutaneous Infusion of ABBV-951 In Adult Participants With Parkinson's Disease
- Is Long-term Use of Amantadine Effective in PD?
- Social Decision Making in Parkinson's Disease
- Bioequivalence Bewteen DopaSnap® (Cabidopa/Levopdoap 25/100 mg Tablet) and Carbidopa/Levodopa 25/100 mg Tablet (Actavis)
- Study of CVN424 in Parkinson's Disease Patients With Motor Fluctuations
- Role of Zonisamide in Advanced Parkinson's Disease (PD) in Egyptian Population: Pilot Study
- Double Randomized and Placebo Controlled Trail of Tianqi Pingchan Granule to Prevent Levodopa-Induced Dyskinesia
- AV-101 (L-4-chlorokynurenine) in Parkinson's Disease Subjects With Levodopa-Induced Dyskinesia
- Brain Correlates of Multimodal Rehabilitation in Chronic Post-stroke Aphasia
- Transition From Acute to Chronic Back Pain : Effect of L-dopa,Gender,and Associated Brain Plasticity
- A Trial of tPCS on Parkinson's Disease OFF State
- Acute Effects of Pharmacological Neuromodulation on Leg Motor Activity in Patients With SCI Treated With EES
- Entacapone Combination With Imatinib for Treatment of GIST
- Impact of Nilotinib on Safety, Tolerability, Pharmacokinetics and Biomarkers in Dementia With Lewy Bodies
- Safinamide for Levodopa-induced Dyskinesia (PD-LID)
- Modulation of Gut Microbiota by Rifaximin in PD Patients
- A Study in Parkinson's Disease in Patients With Moderate to Severe Dyskinesia
- Randomized Placebo Controlled Trial Evaluating the Efficacy of Pimavanserin, a Selective Serotonin 5-HydroxyTryptamine-2A (5HT2A) Inverse Agonist, to Treat Impulse Control Disorders in Parkinson's Disease.
- Sinemet for Spasticity and Function in Amyotrophic Lateral Sclerosis and Primary Lateral Sclerosis
- A Study to Assess the Safety and Effectiveness of Pridopidine Compared to Placebo in the Treatment of Levodopa-Induced Dyskinesia in Patients With Parkinson's Disease
- Pharmacokinetic Study of CVT-301 (Levodopa Inhalation Powder)
- A Study to Evaluate the Efficacy and Safety of Safinamide, as add-on Therapy, in Idiopathic Chinese Parkinson's Disease (PD) Patients With Motor Fluctuations Treated With Stable Doses of Levodopa
- Open Label Extension (OLE) Study of the Safety and Clinical Utility of IPX203 in PD Patients With Motor Fluctuations
- Pilot Trial of Transnasal Nicotine in Parkinson Disease
- Overnight Switch From Rasagiline To Safinamide
- Effect of Safinamide on Parkinson's Disease Related Chronic Pain
- L-DOPA vs. Placebo for Depression and Psychomotor Slowing in Older Adults
- WD-1603 PK Study in Healthy Volunteers
- Safinamide for Multiple System Atrophy (MSA)
- Enhancement of Stroke Rehabilitation With Levodopa
- Effectiveness of Ropinirole and Gabapentin for the Treatment of RLS in Patients on Maintenance HD
- A Study of KW-6356 in Patients With Parkinson's Disease on Treatment With Levodopa-containing Preparations
- A Study to Evaluate the Safety and Efficacy of IPX203 in Parkinson's Disease Patients With Motor Fluctuations
- Dopamine Effect on Inhibitory Control
- PF 06412562 in Subjects With Advanced Stage Parkinson's Disease
- Cannabis Oil for Pain in Parkinson's Disease
- Improving Walking Automaticity in Parkinson's Disease: Levodopa or Donepezil
- Effects of Lingzhi on Disease Progression in Patients With Untreated Early Parkinson's Disease
- A Study of Tolerability and Efficacy of Cannabidiol on Motor Symptoms in Parkinson's Disease
- Study to Assess Pharmacokinetics of Accordion Pill Carbidopa-Levodopa Compared to Immediate Release Carbidopa-Levodopa in Parkinson's Disease Patients
- Microbiota Intervention to Change the Response of Parkinson's Disease
- A Randomized Controlled Trial of Nicotinamide Supplementation in Early Parkinson's Disease
- A Clinical Study of IRL790 in Patients With Parkinson's Disease Experiencing Levodopa Induced Dyskinesia
- A Study of the Pharmacokinetics, Pharmacodynamics, and Safety of Opicapone in Subjects With Parkinson's Disease Taking Levodopa.
- Carbidopa-Levodopa in Dry AMD With Geographic Atrophy
- Study Comparing Intravenous and Subcutaneous Infudopa With Intestinal Duodopa in Patients With Parkinson's Disease
- Docosahexaenoic Acid (DHA) Supplementation in Amblyopia
- A Study of an Investigational Drug to See How it Affects the People With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes) Compared to an Approved Drug Used to Treat People With Parkinson's Disease Complicated by Motor Fluctuati
- Efficacy and Tolerability of IRL790 in Parkinson's Disease Dyskinesia
- Study to Evaluate the Efficacy, Safety, and Tolerability of PXT002331 (Foliglurax) in Reducing Levodopa-Induced Dyskinesia and Wearing OFF in Subjects With Parkinson's Disease Experiencing Motor Complications of Levodopa Therapy (ATTUNED)
- Clinical Studies by Using Alphacait to Screen Drugs for Advanced Solid Tumor
- Lovastatin as a Neuroprotective Treatment for Early Stage Parkinson's Disease
- Clinical Trial of Levodopa/Carbidopa ( Sinemet) Therapy in Angel Man Syndrome
- Measuring Parkinson's Disease Progression
- Extension, Carbidopa-levodopa in Neovascular AMD
- Effects of Droxidopa When Measuring Gait Speed, Kyphosis, and Functional Reach in Parkinson's Disease
- Study to Evaluate the Efficacy, Safety and Tolerability of PXT002331 (Foliglurax) in Reducing Motor Complications of Levodopa Therapy in Parkinson Disease's Patients
- Pharmacokinetic of Levodopa Study in Healthy Males
- Norepinephrine-targeted Therapy for Action Control in Parkinson Disease
- Effect of Long-acting Levodopa on Obstructive Sleep Apnea in Parkinson's Disease
- Does N-Acetylcysteine Decrease Spontaneous Oxidation of Central Neural Dopamine in Parkinson's Disease?
- Modafinil for Freezing of Gait (FOG) in Parkinson's Disease (PD)
- Safety and Efficacy Study of VY-AADC01 for Advanced Parkinson's Disease
- Dose-finding Pharmacokinetic Study in Healthy Males
- Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease.
- Establishing 18F-PBR06 PET Imaging as a Viable Pharmacodynamic Endpoint in MSA
- Dose Ranging Study of Carbidopa-levodopa
- Carbidopa-levodopa in Neovascular AMD
- Comparing the Therapeutic Efficacy and Safety of DA-9701 With Domperidone in Patients With Parkinson's Disease
- A Study to Assess the PK and Pharmacodynamics of IPX203 in Subjects With Advanced Parkinson's Disease
- A Study to Evaluate SAGE-217 in Participants With Parkinson's Disease
- Effect of Continuous Apomorphine During the Night on Sleep Disorders in Insomniac Patients With Parkinson's Disease
- TAME-PD - Physical Therapy, Atomoxetine and, Methylphenidate, to Enhance Gait and Balance in Parkinson's Disease
- A Safety and Efficacy Study of Carbidopa-levodopa in Patients With Macular Degeneration
- Efficacy and Safety of Opicapone in Clinical Practice
- Effect of Two Multiple-dose Regimens of BIA 3-202 on the Pharmacokinetics and Motor Response of Levodopa, and on the Erythrocyte Comt Activity in Parkinson's Disease Patients
- A Study of Tolerability and Efficacy of Cannabidiol on Tremor in Parkinson's Disease
- A Study to Compare Two Dose Strengths of CVT-301 (Levodopa Inhalation Powder) With an Oral Dose of Sinemet® (Carbidopa-levodopa) Tablets
- A Study of the Safety and Tolerability of a Single Dose Administration of CVT-301 (Levodopa Inhalation Powder)
- A Study Comparing Efficacy of Levodopa-Carbidopa Intestinal Gel/Carbidopa-Levodopa Enteral Suspension and Optimized Medical Treatment on Dyskinesia in Subjects With Advanced Parkinson's Disease (DYSCOVER)
- A Clinical Study Investigating the Efficacy, Tolerability, and Safety of Continuous Subcutaneous ND0612 Infusion Given as Adjunct Treatment to Oral Levodopa in Patients With Parkinson's Disease With Motor Fluctuations
- Parkinsonian Brain Repair Using Human Stem Cells
- Pharmacokinetic-pharmacodynamic Interaction Between BIA 3-202 and Levodopa/Benserazide
- Pharmacokinetic-pharmacodynamic Interaction Between BIA 3-202 and Levodopa/Carbidopa
- Efficacy of Levodopa/Benserazide Dispersible Tablet on Response Fluctuations in PD Patients With Delayed ON
- Efficacy and Safety Proof of Concept Study in Patients With Parkinson's Disease and End-of-dose Wearing-off (COMPOC)
- Pharmacokinetic-Pharmacodynamic Interaction Between Four Different Single Doses of BIA 3-202 and a Single Dose of Levodopa/Benserazide (100/25 mg)
- Pharmacokinetic-Pharmacodynamic Interaction Between Four Different Single Doses of BIA 3-202 and a Single Dose of Levodopa/Carbidopa (100/25 mg)
- Intermittent Oral Administration vs. Semi-continuous Intra-oral Administration of Levodopa/Carbidopa in Fluctuating Parkinsonian Patients
- A Study of L-DOPA for Depression and Slowing in Older Adults
- Levodopa Benserazide Generic Formulation Versus the Originator
- A Clinical Study in Advanced Parkinson's Disease Investigating the Long Term Safety of ND0612 Administered as a Continuous SC Infusion
- Mucuna Pruriens Therapy in Parkinson's Disease
- Efficacy Phase IIa Study of CVXL-0107 in Advanced Parkinson's Disease
- A Study of the Safety and Levodopa Pharmacokinetics Following Single Dose Administration of CVT 301 (Levodopa Inhalation Powder) in Smoking and Non-Smoking Adults
- A Study of the Safety and Pharmacokinetics of Levodopa Following Administration of CVT 301 (Levodopa Inhalation Powder) in Adults With Asthma
- Buspirone Treatment of Iatrogenic Dyskinesias in Advanced Parkinson' Disease
- Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
- A Study to Assess the Safety and Efficacy of the of the Gastric-retentive AP-CD/LD in Advanced Parkinson's Patients
- A Sequential Two-Part, Open-Label Study in Healthy Male and Female Subjects
- Effects of PR Oxycodone and of Levodopa, vs Placebo, on Central Neuropathic Pain in Parkinson's Disease
- Buspirone, in Combination With Amantadine, for the Treatment of Levodopa-induced Dyskinesia
- A Study of Weekly Subcutaneous Injections of SER-214 in Subjects With Parkinson's Disease (PD), to Determine the Safety, Tolerability and Pharmacokinetic (PK) Profile of SER-214
- A Clinical Study Investigating the Efficacy, Safety, Tolerability and Pharmacokinetics of ND0612H, a Solution of Levodopa/Carbidopa Administered as a Continuous Subcutaneous Infusion in Subjects With Advanced Parkinson's Disease
- Dopamine Enhancement of Fear Extinction Learning in PTSD (1R21MH108753)
- Pharmacokinetic Study in Healthy Volunteers
- Outpatient Physical Therapy Intervention in Subjects With Parkinson's Disease Currently Using APOKYN®
- A Study to Examine the Effect of Levodopa-Carbidopa Intestinal Gel (LCIG) Therapy Relative to That of Optimized Medical Treatment (OMT) on Non-motor Symptoms (NMS) Associated With Advanced Parkinson's Disease (PD)
- Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients With Parkinson's Disease
- Using [18F]FDOPA PET/CT to Monitor the Effectiveness of Fetal Dopaminergic Grafts in Parkinson Disease Patients
- Inflammation-related Alterations in Neurocircuitry: Reversal With Levodopa
- A Single Period Investigation to Assess the Tolerability of Healthy Subjects to Oral Sinemet® (Levodopa/Carbidopa)
- INfusion VErsus STimulation in Parkinson's Disease
- Efficacy, Safety and Tolerability Study of APL-130277 for the Acute Treatment of OFF Episodes in Patients With Parkinson's Disease
- Safety and Efficacy Study of Tozadenant to Treat End of Dose Wearing Off in Parkinson's Patients
- Clock and Narcolepsy Genetic Variants and the Effects of Stalevo® (Levodopa/Carbidopa/Entacapone) on Sleep Disorders in Parkinson's Disease
- A Study to Compare Plasma Levels of Levodopa, Carbidopa and Entacapone After TRIGEL or Duodopa Infusion in PD Patients
- Efficacy and Safety of JM-010 in PD With Levodopa-Induced Dyskinesia
- A Study of Efficacy and Safety of Eltoprazine HCl for Treating Levodopa-induced Dyskinesia in Parkinson's Disease Patients
- Effect of Serotonin and Levodopa in Ischemic Stroke
- Fesoterodine on Urgency Episodes in Parkinson's Disease Population
- Randomized Safety Study of CVT-301 Compared to an Observational Control Group
- L-dopa Versus Dopamine Agonists After Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease
- Combining Robotic-Assisted Therapy and Pharmacotherapy in Post-Stroke Rehabilitation
- Infusion of Apomorphine: Long-term Safety Study
- A Long-term, Phase 3 Study of TVP-1012 (1 mg) in Levodopa Treated Parkinson's Disease Participants
- A Phase 3, Long-term, Extension Study of TVP-1012 (1 mg) in Early Parkinson's Disease Participants
- A Phase 2/3 Study of TVP-1012 at 0.5 mg or 1 mg in Levodopa Treated Parkinson's Disease Participants
- A Phase 3 Study of TVP-1012 (1 mg) in Early Parkinson's Disease Patients
- Pharmacokinetic Study in Healthy Males
- Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia
- A Study to Assess the PK and Pharmacodynamics of IPX203 in Patients With Advanced Parkinson's Disease
- Twelve Month Safety and Efficacy Study of CVT-301 In Parkinson's Disease Patients With OFF Episodes
- Efficacy and Safety Study of CVT-301 In Parkinson's Disease Patients With OFF Episodes
- Sagene 2014 - Parkinson's Disease and Erectile Dysfunction
- Open-Label Safety Study of ADS-5102 in PD Patients With LID
- Pramipexole in Untreated and Levodopa-treated Parkinson's Disease Patients
- The Effect of BIA 9-1067 at Steady-state on the Levodopa Pharmacokinetics
- Pharmacokinetic-pharmacodynamic Interaction Between Three Different Single Doses of BIA 9-1067 and a Single-dose of Immediate-release Levodopa/Benserazide
- Pharmacokinetic-pharmacodynamic Interaction Between Each of Three Diferente Single Doses of BIA 9-1067 and a Single-dose of Immediate-release 100/25 mg Levodopa/Carbidopa
- Pharmacokinetic-pharmacodynamic Interaction Between Three Different Single Doses of BIA 9-1067 and a Single-dose of Controlled-release 100/25 mg Levodopa/Benserazide
- Pharmacokinetic-pharmacodynamic Interaction Between Each of Three Different Single Doses of BIA 9-1067 and a Single-dose of Controlled-release 100/25 mg Levodopa/Carbidopa
- Effect of Three Multiple-dose Regimens of BIA 9 1067 at Steady-state on the Levodopa Pharmacokinetics
- Efficacy and Safety of Amantadine Hydrochloride (HCl) ER Tablets to Treat Parkinson's Disease Patients With LID.
- Efficacy and Safety of Amantadine Hydrogen Chloride (HCl) ER Tablets in Parkinson's Disease Subjects With LID
- ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
- Safety and Tolerability of Perampanel in Cervical Dystonia
- Pharmacokinetic Study With Levodopa-carbidopa Fixed-dose Products in Healthy Subjects After Oral Administration
- Effects of Helicobacter Pylori Infection Eradication in Patients With Parkinson's Disease
- Helicobacter Pylori Eradication Study in Parkinson's Disease
- A Pharmacokinetic Study of ND0612 Delivered as a Continuous Subcutaneous in Parkinson's Disease Patients
- Combinational Rehabilitative Therapy and Functional Brain Imaging for Patients Recovering From Motor Stroke
- Efficacy of L-threo DOPS on Orthostatic Hypotension Symptoms and Other Non-motor Symptoms in Patients With MSA
- Clinical Trial of Apomorphine Subcutaneous Infusion in Patients With Advanced Parkinson's Disease
- Erythromycin in Parkinson's Disease
- Orthostatic Dysregulation and Associated Gastrointestinal Dysfunction in Parkinson's Disease -Treatment
- A 12-week Randomized Study to Evaluate Oral Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
- A Study to Assess the Efficacy, Safety and Tolerability of ABT-SLV187 Monotherapy in Subjects With Advanced Parkinson's Disease (PD) and Persistent Motor Complications, Despite Optimized Treatment With Available Anti-Parkinsonian Medications
- Effect of L-dopa In Subacute Back Pain Population
- Targeting Dopamine Therapy in RLS
- Famotidine for Levodopa-induced Dyskinesia in PD
- A Phase 2a Study Followed to Evaluate the Safety, Tolerability and Levodopa Pharmacokinetics in Levodopa-treated Parkinson's Disease Patients Receiving ND0612
- Cholinesterase Inhibitors to Slow Progression of Visual Hallucinations in Parkinson&Apos;s Disease
- Phase 2A Study of GM 608 in Mild to Moderate Parkinson Disease
- Efficacy and Safety Study of Inhaled CVT 301 in Parkinson's Disease Patients for Treatment of OFF Episodes
- Apokyn for Motor IMProvement of Morning AKinesia Trial (AM IMPAKT)
- Safety and Efficacy of AVP-923 in the Treatment of Levodopa-induced Dyskinesia in Parkinson's Disease Patients
- Efficacy and Safety Proof of Concept Study in Patients With Parkinson's Disease and End-of-dose Motor Fluctuations
- Clinical Trial of Rasagiline in Levodopa-Treated Parkinson's Disease Patients With Motor Fluctuations
- A Study to Assess the Safety and Efficacy of Levodopa-carbidopa Intestinal Gel (LCIG) for the Treatment of Non-motor Symptoms in Patients With Advanced Parkinson's Disease
- A Phase I/IIa Study of Safety, Tolerability and Plasma Concentration of Subcutaneous Continuously-delivered Levodopa/Carbidopa Solution (ND0612) in PD Patients
- Remission of ICD by Switching Dopamine Agonist to Levodopa/Carbidopa
- Vision Response to Dopamine Replacement
- Rotigotine Versus Placebo, A Study To Evaluate The Efficacy In Advanced Stage Idiopathic Parkinson's Disease Patients
- Safety, Pharmacokinetics and Efficacy Study of CVT-301 Inpatients With Parkinson's Disease and "Off" Episodes
- Evaluation of the Subjective and Objective Painful Threshold in Multiple System Atrophy Pain and Multiple System Atrophy
- Efficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients With "Wearing-off" Phenomenon
- Multicentre Study in Four Parallel Groups of Parkinson's Disease (PD) Patients
- A Study to Investigate the Tolerability and Effect of Three Single-dose Regimens of BIA 9-1067
- Reducing Dyskinesia in Parkinson's Disease With Omega-3 Fatty Acids
- Rasagiline in Early Parkinson's Disease Patients Not Treated With Levodopa in China
- Cardiovascular Events in Parkinson's Disease Patients
- Amantadine and L-DOPA-induced Dyskinesia in Early Parkinson's Disease
- Effect of BIA 9-1067 at Steady-state on the Pharmacokinetics of Levodopa/Carbidopa and Levodopa/Benserazide
- Pharmacokinetic Interaction Between BIA 9-1067 and Standard-release Levodopa/Carbidopa
- Cognitive Enhancement as a Target for Cocaine Pharmacotherapy
- PharmacoMRI of Parkinson Disease
- Study of BIA 9-1067 to Investigate Its Effect on Levodopa Pharmacokinetic
- Study in Advanced Parkinson's Disease Patients With Predictable Motor Fluctuations
- Single Dose Study to Assess the Pharmacokinetics of SCH 900800 in Subjects With Parkinson's Disease Being Treated With Levodopa (L-DOPA) (P08235)
- Study of Subcutaneous Continuous Administration of Levodopa/Carbidopa Solution (ND0612) in Healthy Volunteers
- A Pharmacokinetic Study of Levodopa and Carbidopa Intestinal Gel in Subjects With Advanced Parkinson's Disease
- Study to Assess Safety, Tolerability and MTD of a Central Pattern Generator-activating Tritherapy (SPINALON) in Patients With Chronic Spinal Cord Injury
- Azilect® (Rasagiline) in Levodopa-treated Parkinson's Patients With Motor Fluctuations in China
- The Effect of Pramipexole on Metabolic Network Activity Compared With Levodopa in Early Parkinson's Disease
- Imaging the Neurobiology of Behavioral and Medication Treatment for Cocaine Dependence
- Effects of Rasagiline on Sleep Disturbances in Parkinson's Disease
- Behavioral and Physiological Effects of Cocaine in Cocaine-dependent Participants Treated With Levodopa in Combination With Carbidopa and Entacapone (LCE)
- Augmenting Language Therapy for Aphasia: Levodopa
- Carbidopa-Levodopa (CD-LD) ER Alone or in Combination With CD-LD IR to IPX066 Followed by IPX066 Extension Safety Study
- High and Low Dose Carbidopa Treatment of Parkinson's Disease
- Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
- Emotion, Mood and Executive Function in Parkinson's Disease (PD)
- The Effect of Rasagiline on Cognition in Parkinson's Disease
- Use of Zolpidem in Parkinson's Disease
- ADX48621 for the Treatment of Levodopa Induced Dyskinesia in Patients With Parkinson's Disease
- Study to Assess Droxidopa in the Treatment of Freezing Of Gait Symptoms in Patients With Parkinson's Disease
- Selegiline Patch for Treatment of Nicotine Dependence
- Fasting Comparative Bioavailability of Two Tablet Formulations of Levodopa /Benserazide in Healthy Volunteers
- Effect of Intravenous Amantadine on Gait Freezing in Parkinson's Disease
- Comparing Different Levodopa/Carbidopa/Entacapone Treatment Regimens
- A Dose Finding Study of Preladenant (SCH 420814) for the Treatment of Parkinson's Disease (PD) in Japanese Patients (P06402)
- Clinical and Economic Impact of Duodopa: Long-term Effectiveness Study in Advanced Parkinson's Disease Patients
- 18-month Study of Long-term Efficacy & Safety of Safinamide as add-on Therapy in Patients With Mid-late Stage PD
- Safety and Efficacy Study of SYN115 in Parkinson's Patients Using Levodopa to Treat End of Dose Wearing Off
- A Trial of Levodopa in Angelman Syndrome
- Study of Azilect® (Rasagiline) in Levodopa-treated Parkinson's Disease Patients With Motor Fluctuations in Korea
- A Safety, Tolerability and Pharmacokinetic Study of ND0611 on the Top of Different Oral Dosage Forms of Levodopa/Carbidopa in Parkinson's Disease Patients
- Efficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients.
- Placebo Controlled Study of Preladenant in Participants With Moderate to Severe Parkinson's Disease (P07037)
- Dopaminergic Modulation of Cognition and Psychomotor Function
- An Active-Controlled Extension Study to NCT01155466 [P04938] and NCT01227265 [P07037] (P06153)
- Carbidopa for the Treatment of Nausea and Vomiting in Familial Dysautonomia
- Pramipexole Extended Release Versus Pramipexole Immediate Release for 18 Weeks in Chinese Parkinson's Disease (PD) Patients
- Levodopa for the Treatment of Residual Amblyopia
- Caffeine for Motor Manifestations of Parkinson's Disease
- Efficacy and Safety of Safinamide (50 and 100mg/Day) Versus Placebo, in Patients With Mid-late Stage Parkinson's Disease
- Trial of L-DOPA as a Treatment to Improve Vision in Albinism
- A Efficacy, Safety and Pharmacokinetic Study of XP21279 and Sinemet® in Parkinson's Disease Subjects
- A Study Comparing the Safety and Tolerability of Two Doses of Fipamezole in Adult Patients With Parkinson's Disease
- Tetrahydrobiopterin Treatment in Children With Idiopathic Cognitive Developmental Disorders
- A Study of Safety and Tolerability of Fipamezole in Adult Subjects With Parkinson's Disease Who Are Receiving Levodopa
- A Study to Compare IPX066 and Carbidopa/Levodopa/Entacapone (CLE) Followed by an Open-Label Safety Study of IPX066
- Safinamide in Levodopa Induced Dyskinesia in Parkinson's Disease Subjects
- Safety, Tolerability and Pharmacokinetic Profile of Levodopa Administered With Continuous Administration of ND0611
- An Open Label Extension Study of the Safety and Clinical Utility of IPX066 in Subjects With Parkinson's Disease
- Levodopa Concentration Profile With Stalevo 75/125 mg
- Extended Long-Term Safety Study of KW-6500
- Placebo-Controlled Double-Blind Crossover Comparative Study of KW-6500
- Motor Activation in Multiple System Atrophy and Parkinson Disease: a Positron Emission Tomography (PET) Study
- A Study to Assess the Effect of Safinamide on Levodopa Pharmacokinetics
- Safety and Tolerability Study Evaluating ACR325 in Parkinson's Disease Patients
- Influence of Piribedil (Clarium®) on Vigilance and Cognitive Function in Patients With Parkinson's Disease Compared to Other Non-Ergot Dopamine Agonists
- Natural History of Levodopa-Induced Dyskinesia (LID)
- A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).
- Study of NP002 in Subjects With Idiopathic Parkinson's Disease to Treat Dyskinesias Due to Levodopa Therapy
- Long-Term Safety Study of KW-6002 (Istradefylline) in Parkinson's Disease Patients
- Study of KW-6002 (Istradefylline) for the Treatment of Parkinson's Disease in Patients Taking Levodopa
- Long-Term Safety Study of KW-6500 in Patients With Parkinson's Disease
- A Long-Term, Safety Study With a Flexible Dose Range of KW-6002 in Patients With Motor Response Complications on Levodopa/Carbidopa Therapy
- Gastric Retentive Carbidopa/ Levodopa in Parkinson's Patients; a One Year, Open Label, Safety Extension Study
- Effect of Dopaminergic Medication on Recovery of Aphasia
- Duodenal Levodopa Infusion, Quality of Life and Autonomic Nervous System in Parkinson's Disease
- Amitiza in Constipation Associated With PD (Parkinson's Disease)
- Pharmacokinetics of Levodopa/Carbidopa Infusion With and Without Oral Catechol-O-methyl Transferase (COMT) Inhibitors
- A Pilot Study to Assess Efficacy and Safety of Pardoprunox as Adjunct Therapy to L-dopa in the Treatment of Patients With Parkinson's Disease Experiencing Motor Fluctuations and Dyskinesia.
- Different Dyskinesias in Parkinson's Disease and Their Relation to Levodopa Pharmacokinetics
- A Study to Compare Pharmacokinetics and Pharmacodynamics of IPX066 to Standard Carbidopa-Levodopa
- Acute Effects of Preladenant (SCH 420814) on Dyskinesia and Parkinsonism in Levodopa Treated Participants (P05550)
- Study on Tolerability of Levodopa/Carbidopa in Children With Angelman Syndrome
- Effect of Levodopa on Human Multifocal Electroretinogram
- Quantification of the Antidyskinetic Effect of Amantadine and Topiramate in Parkinson's Disease
- Pilot Study to Evaluate Levodopa as Treatment for Residual Amblyopia
- Comparison of Continuous and Pulsatile Apomorphine in Parkinson's Disease
- High and Low Dose Carbidopa Treatment of Parkinson's Disease
- Carbidopa/Levodopa Combined With Behavioral Therapy for the Treatment of Cocaine Dependence
- Pharmacokinetic Study With Repeated Doses of Stalevo
- Effects of a Dopamine Agonist on Pharmacodynamics of Levodopa in Parkinson's Disease
- Treating H. Pylori in Parkinson's Patients With Motor Fluctuations
- Open Label Continuation Treatment Study With Levodopa-Carbidopa Intestinal Gel in Advanced PD
- Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects
- Carbidopa/Levodopa/Entacapone Versus Immediate Release (IR) Carbidopa/Levodopa on Non-motor Symptoms in Patients With Idiopathic Parkinson's Disease and Demonstrating Non-motor Symptoms of Wearing Off
- Tolerability and Efficacy of Switch From Oral Selegiline to Orally Disintegrating Selegiline (Zelapar) in Patients With Parkinson's Disease
- Dopaminergic Effects on Cortical Function in Tourette's (Levodopa Protocol)
- Long-Term Effects of Amantadine in Parkinsonian (AMANDYSK)
- Safinamide in Idiopathic Parkinson's Disease (IPD) With Motor Fluctuations, as add-on to Levodopa
- A Study to Determine the Efficacy and Safety of Cabergoline for the Treatment of Patients With RLS
- Compassionate Use Study of Pergolide in Patients With Parkinson's Disease
- Phase 2 Clinical Study of KW-6500 in Parkinson's Disease Patients With Motor Response Complication on Levodopa Therapy
- Safety, Tolerability, PK and PD Study of Neu-120 in the Treatment of Levodopa-induced Dyskinesia
- Study to Evaluate SYN115 in Parkinson's Disease
- Carbidopa/Levodopa Versus Carbidopa/Levodopa/Entacapone on Markers of Event Related Potentials (ERPs) in Patients With Idiopathic Parkinson's Disease (PD) and End-of-dose Wearing Off
- An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Advance-Stage Parkinson's Disease
- Parcopa Versus Carbidopa-Levodopa in a Single Dose Cross-Over Comparison Study
- Treatment of Orthostatic Hypotension
- PET-Study: Effects of Single Doses of Stalevo and Levodopa/Carbidopa on Striatal 11C-Raclopride Binding
- Ranibizumab Therapy for Non-arteritic Ischemic Optic Neuropathy
- A 12-week Study of Pramipexole Extended Release (ER) in Patients With Parkinson's Disease (PD), Followed by a 52-week Long-term Treatment Period
- Safety and Efficacy Study of Fipamezole in Treatment of Motor Dysfunctions in Parkinson's Disease
- Efficacy, Safety, and Pharmacokinetics/Pharmacodynamic Study of L-Dopa/Carbidopa To Treat Parkinson's Disease
- Augmenting Effects of L-DOPS With Carbidopa and Entacapone
- Apomorphine Effect on Nociceptive Perception in Parkinson's: a Clinical and Imaging Study
- Study of the Modification of the Pharmacokinetic Profile of Levodopa by the Fiber Plantago Ovata Husk
- A Study of MK0657 in Parkinson's Disease Patients (0657-006)
- Evaluation of the Long-term Safety, Tolerability, and Efficacy of Perampanel (E2007) as an Adjunctive Therapy in Levodopa Treated Parkinson's Disease Subjects With Motor Fluctuations
- An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Advanced-Stage Parkinson's Disease
- PK, PD and Safety of Multiple Doses of V1512 Tablets in PD Patients Compared to Standard Levodopa/Carbidopa Oral Tablets
- Low Dose Apomorphine and Parkinsonism
- Developing Objective Measures of Levodopa Induced Dyskinesia: (Study 1)
- Pivotal Study in Advanced Parkinsons Disease Patients
- Study to Evaluate Initiation of Stalevo in Early Wearing-off
- A Multiple-Dose Study of Sinemet® CR (Carbidopa/Levodopa) in Healthy Subjects
- 12-Week, Double-Blind, Placebo-Controlled Study of 20 and 60 mg/Day Istradefylline in Parkinson's Disease Patients on Levodopa/Carbodopa
- 12-Week, Double-Blind, Placebo-Controlled, Randomized Study of the Efficacy of 40 mg/Day KW-6002 in Parkinson's Disease Patients on Levodopa/Carbidopa
- A Phase 2b Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking Levodopa
- The Effect Of E2007 On Pharmacodynamic Responses To Levodopa Among Patients With Parkinson's Disease Who Experience Dyskinesia And Motor Fluctuations
- Efficacy of Orally Disintegrating Selegiline in Parkinson's Patients Experiencing Adverse Effects With Dopamine Agonists
- Dose-Finding Safety Study of BIIB014 in Combination With Levodopa in Moderate to Late Stage Parkinson's Disease
- Effect of Levodopa-Carbidopa on Visual Function in Patients With Recent-Onset Nonarteritic Anterior Ischemic Optic Neuropathy
- Bioequivalence Study of Carbidopa/Levodopa/Entacapone Combination vs. Carbidopa/Levodopa Combination Plus Entacapone in Healthy Volunteers
- Bioequivalence Study of Carbidopa/Levodopa/Entacapone Combination vs. Carbidopa/Levodopa Combination Plus Entacapone Under Fasting Conditions in Healthy Volunteers
- Bioequivalence Study of Carbidopa/Levodopa/Entacapone Combination vs. Carbidopa/Levodopa Combination Plus Entacapone in Healthy Volunteers
- Bioequivalence Study of Carbidopa/Levodopa/Entacapone Combination vs. Carbidopa/Levodopa Combination Plus Entacapone in Healthy Volunteers
- SLV308 for Treatment of Patients With Parkinson's Disease Experiencing Motor Fluctuations
- A Non-Blinded Study Demonstrating the Effectiveness and Safety of Azilect Alone or in Combination Therapy in Parkinson's Disease
- Efficacy of Levodopa/Carbidopa/Entacapone vs Levodopa/Carbidopa in Parkinson's Disease Patients With Early Wearing-off
- Efficacy, Safety, and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations
- Onset Motor Complications Using REQUIP CR (Ropinirole Controlled-release) As Add-on Therapy To L-dopa In Parkinson's
- Safety/Efficacy Study of Levodopa-Carbidopa Intestinal Gel in Parkinson's Subjects
- A Study of E2007 as an Adjunctive Therapy in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations
- Efficacy, Safety and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations
- Methylphenidate and Parkinson's Disease
- Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects
- Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced Parkinson's Disease
- Efficacy and Safety of Levetiracetam Versus Placebo on Levodopa-induced Dyskinesias in Advanced Parkinson's Disease
- Dopaminergic Enhancement of Learning and Memory in Healthy Adults and Patients With Dementia/Mild Cognitive Impairment
- Topiramate as a Treatment for Levodopa-Induced Dyskinesia in Parkinson's Disease
- Levetiracetam Administration for the Management of Levodopa-Induced Dyskinesias in Parkinson's Disease
- The Efficacy, Safety and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations
- Deep Brain Stimulation (DBS) for Early Stage Parkinson's Disease (PD)
- Comparison of IPX054, IR Carbidopa-Levodopa, and CR Carbidopa-Levodopa in Subjects With Parkinson's Disease
- Continuous Delivery of Levodopa in Patients With Advanced Idiopathic Parkinsons Disease - Cost-benefit
- Comparison of IPX054 and Immediate-Release Carbidopa-Levodopa in Patients With Parkinson's Disease
- Comtess® Versus Cabaseril® as Add-on to Levodopa in the Treatment of Parkinsonian Patients Suffering From Wearing- Off.
- Rotigotine Patch in Subjects With Advanced Stage, Idiopathic Parkinson's Disease Who Are Not Well Controlled on Levodopa
- Pharmacokinetics and Pharmacodynamics of IPX054 in Subjects With Parkinson's Disease
- POETRY: Study of Estrogen Replacement Therapy in Postmenopausal Women With Parkinson's Disease
- Study of the Effect of SR57667B on 18F-Dopa PET Imaging in Patients With Parkinson's Disease
- Effects of Carbidopa/Levodopa/Entacapone on Motor Function and Quality of Life in Patients With Parkinson's Disease
- Behavioral Therapy Combined With Carbidopa/Levodopa for the Treatment of Cocaine Dependence
- Medications for Stopping Cocaine Dependence and Preventing Relapse
- Study of KW-6002 (Istradefylline) in Parkinson's Disease in Patients With Motor Response Complications on Levodopa
- Rasagiline in Advanced Parkinson's Disease Patients With Motor Fluctuations Treated With Levodopa/Carbidopa Therapy.
- Study to Evaluate the Safety and Tolerability of Rasagiline in Advanced Parkinson's Disease Patients
- Effectiveness, Tolerability and Safety of Rasagiline in Early Parkinson's Disease Patients Not Treated With Levodopa
- Multicenter Study of Rasagiline in Parkinson's Disease Patients Using Levodopa and Experiencing Motor Fluctuations
- An Open-Label Feasibility/Pilot Study With [123I]-IBZM SPECT (DOPA-SYN)
- A Study of Istradefylline (KW-6002) in Treating Patients With Parkinson's Disease on Levodopa
- A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking Levodopa
- A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease
- An Extension of Istradefylline in North American Parkinson's Disease Patients Who Have Completed Study 6002-INT-001
- An Extension of Istradefylline in Parkinson's Disease Patients Who Have Completed Studies 6002-EU-007, 6002-US-013 or 6002-US-018
- A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking Levodopa
- Study Of Cabaser and Sinemet CR For The Treatment Of Nighttime Symptoms Associated With Parkinson's Disease.
- Levetiracetam Treatment in Adult Subjects With Parkinson's Disease Experiencing Troublesome Dyskinesias
- Dopamine Turnover Rate as Surrogate Parameter for Diagnosis of Early Parkinson's Disease
- A Randomized, Double-blind, Placebo-controlled, Five Parallel Groups Efficacy and Safety Study of NS 2330 (Tesofensine) (0.125 mg, 0.25 mg, 0.5 mg and 1.0 mg) Administered Orally Once Daily Over 14 Weeks in Levodopa Treated Parkinson Patients With M
- Assess Efficacy and Safety of the Dopamine Agonist Pramipexole Versus Levodopa / Benserazide (Madopar® DR) in Patients With Restless Legs Syndrome
- Study to Compare the Effect of Treatment With Carbidopa/Levodopa/Entacapone on the Quality of Life of Patients With Parkinson's Disease. This Study is Not Recruiting in the United States
- Long-term Study of Duodopa (Levodopa/Carbidopa) in Advanced Parkinson's: Health Outcomes & Net Economic Impact
- A Single Center, Randomized, Double-blind, Crossover Pilot Trial Comparing the Onset of Action of Parcopa™ With Sinemet® in Subjects With Stable Parkinson's Disease
- A Multicenter, Open-label Trial to Assess Subject Preference of PARCOPA, Carbidopa/Levodopa Orally Disintegrating Tablets, Compared to Conventional Carbidopa/Levodopa Tablets in Subjects With Stable Parkinson's Disease
- A Study to Evaluate Fixed Dose Carbidopa/Levodopa/Entacapone Versus Immediate Release Carbidopa/Levodopa
- Long-Term Dopamine Transporter Imaging and Clinical Assessment of Parkinson's Disease Progression
- Study of the Effects of Dopaminergic Medications on Dopamine Transporter Density in Subjects With Parkinson's Disease
- Potentiation of Procedural Motor Learning in Health and Disease
- Stalevo in Early Wearing-Off Patients
- Study of Liatermin (r-metHuGDNF) Administered by Bilateral Intraputaminal (IPu) Infusion to Subjects With Idiopathic Parkinson's Disease
- Dopaminergic Enhancement of Learning and Memory in Healthy Adults and Patients With Dyslexia
- Talampanel to Treat Parkinson's Disease
- Improved Language Acquisition With Levodopa
- Dopaminergic Enhancement of Learning and Memory in Aphasia
- Neuromodulation and Language Acquisition (Stage Ib)
- Neuromodulation and Language Acquisition (Project Stage Ia)
- Efficacy and Safety of Carbidopa/Levodopa/Entacapone in Patients With Parkinson's Disease Requiring Initiation of Levodopa Therapy
- Study of the Effects of Dopaminergic Medications on Dopamine Transporter Imaging in Parkinson's Disease
- Lisuride Patch to Treat Parkinson's Disease
- ACP-103 to Treat Parkinson's Disease
- Levetiracetam Treatment of L-dopa Induced Dyskinesias
- JP-1730 to Treat Parkinson's Disease
- Riluzole to Treat Parkinson's Disease
- EMD 128130 for the Treatment of Parkinson's Disease
- Continuously Infused Intracerebral (IC) Recombinant-Methionyl Human Glial Cell Line-Derived Neurotrophic Factor (r-metHuGDNF) for the Treatment of Idiopathic Parkinson's Disease
- KW-6002 to Treat Parkinson's Disease
- Effects of Monoamine Reuptake Inhibitor NS2330 in Parkinson's Disease
- Timing of Levodopa Treatment in Parkinson's Disease
- Parkinson's Disease Treatment With Coenzyme Q10
- Study of LY300164 for the Treatment of Parkinson's Disease
- Treatment of Parkinson's Disease With Eliprodil
Clinical trials list
click for details